Albumin and Other Plasma Proteins in Pediatric Patients: What, When, and How Much They Influence Antimicrobial...

Area of Science:

• Pharmacology
• Clinical Pharmacy
• Pediatric Therapeutics

Background:

• Plasma protein binding influences antimicrobial drug exposure and efficacy.
• Special populations, particularly pediatric patients, exhibit altered protein concentrations and binding capacity.
• Age-related physiological development impacts drug pharmacokinetics.

Purpose of the Study:

• To review age-related changes in plasma protein concentrations and binding variability.
• To highlight the impact on antimicrobial pharmacokinetics in pediatric populations.
• To emphasize the importance of understanding these changes for optimizing drug dosing.

Main Methods:

• Literature review of studies on plasma protein binding and antimicrobial pharmacokinetics.
• Focus on pediatric populations across developmental stages (birth to adolescence).
• Analysis of how protein binding variability affects the unbound fraction of antimicrobials.

Main Results:

• Significant variability in plasma protein concentrations and binding occurs with age, especially in pediatrics.
• Highly protein-bound antimicrobials are particularly susceptible to altered unbound fractions.
• Pharmacokinetic parameters change rapidly and variably during pediatric development.

Conclusions:

• Understanding age-dependent pharmacokinetic changes is fundamental for safe antimicrobial therapy in children.
• Specific dose adjustments are often necessary for pediatric patients due to developmental variations.
• Therapeutic drug monitoring (TDM) is essential for optimizing antimicrobial dosing and achieving therapeutic targets in pediatric populations.